Genevention is a bioinformatics company that brings together long-standing experience in semantic integration of biomedical big data, cutting-edge deep data analyses and sharp visualizations for interactive data exploration. Our aim is to combine these technologies to allow biomedical researchers, pharmaceutical engineers and bioinformaticians to discover disease-specific biomarkers, reveal novel correlations in datasets across different experiment types and easily enrich experimental data with information from the literature and external databases. Our services include the custom-tailored development of semantic data integration systems, the provision of expert-curated biomarker knowledge bases based on high-throughput-omics data and the investigation of biomedical big data using artificial intelligence approaches.
Dr. Thomas Lingner
CEO
Thomas is a data scientist with a strong background in computational biology. His expertise covers data mining & machine learning, high-throughput sequence analysis and metagenomics.
Prof. Dr. Stefan Bonn
Co-founder / Advisory Board
Stefan is a biochemist and computational biologist with a strong background in deep learning and data analysis.
Dr. Herbert Stadler
Co-founder / Advisory Board
Herbert is a neuroscientist and successful biotech entrepreneur.
Publications
|
Title: A distinct transcriptional signature of antidepressant response in hippocampal dentate gyrus granule cells
|
|---|
|
Title: Ribosome Pausing at Inefficient Codons at the End of the Replicase Coding Region Is Important for Hepatitis C Virus Genome Replication
|
|
Title: Deep learning-based cell composition analysis from tissue expression profiles
|
|
Title: The secreted BMP antagonist ERFE is required for the development of a functional circulatory system in Xenopus
|
|
Title: DNA Methylation-Mediated Modulation of Endocytosis as Potential Mechanism for Synaptic Function Regulation in Murine Inhibitory Cortical Interneurons
|
